Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome

Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome

Background: The clustering of cardiovascular risk factors is termed the metabolic syndrome (MS), which strongly predicts the risk of diabetes and cardiovascular disease (CVD). Adipokines may contribute to the development of obesity and insulin resistance and may be a causal link between MS, diabetes...

Full description

Bibliographic Details
Main Authors: M K Garg, M K Dutta, Namita Mahalle
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Adiponectin
hsCRP
insulin resistance
metabolic syndrome
plasminogen activator inhibitor-1
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=1;spage=116;epage=123;aulast=Garg

Internet

http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=1;spage=116;epage=123;aulast=Garg

Similar Items